A clinical audit of venous thromboprophylaxis in multiple myeloma

被引：0
|
作者：
Lyengar, S. [1 ,2 ]
Ayto, R. [1 ,2 ]
Wechalekar, A. [1 ,2 ,3 ]
Dwanga, F. [1 ,2 ]
Mehta, A. B. [1 ,2 ]
Hughes, D. A. [1 ,2 ]
机构：
[1] Royal Free Hosp, Dept Acad Haematol, London NW3 2QG, England
[2] Univ Coll Med Sch, London, England
[3] Royal Free Hosp, Natl Amyloidosis Ctr, London NW3 2QG, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2009年 / 145卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
26
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] An audit of thromboprophylaxis for patients with myeloma on the immunomodulatory therapies: thalidomide, lenalidomide or pomalidomide
    Melly, M.
    Al-Talib, M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 186 - 186
  • [22] Thalidomide thromboprophylaxis in multiple myeloma: A review of current evidence
    Alexander, Marliese
    Kirsa, Sue
    Mellor, James D.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (04) : 319 - 324
  • [23] Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs
    Paydas, Semra
    LEUKEMIA & LYMPHOMA, 2008, 49 (08) : 1644 - 1645
  • [24] Thromboprophylaxis in Patients Admitted to the Surgical Ward: Clinical Audit
    Abdalla, Yassin Abdelrahim
    Kamil, Arwa Mustafa
    Mohamed, Samya Abbas Abdelrazig
    Mohamed, Ahmed Hashim Ahmed
    Khalifa, Eman
    Mohamed, Mohamed Hamid Abdelsalam
    Abdelgadir, Eilaf Eltayeb Abdalla
    Dabora, Muawiya
    Awoda, Mohammed Salah Eldin Mohammed Elshikh
    VASCULAR HEALTH AND RISK MANAGEMENT, 2023, 19 : 651 - 656
  • [25] Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis
    Anaissie, Elias J.
    Coleman, Elizabeth A.
    Goodwin, Julia A.
    Kennedy, Robert L.
    Lockhart, Kimberly D.
    Stewart, Carol B.
    Coon, Sharon K.
    Bailey, Clyde
    Barlogie, Bart
    CANCER, 2012, 118 (02) : 549 - 557
  • [26] Venous Thromboembolism in Multiple Myeloma
    De Stefano, Valerio
    Za, Tommaso
    Rossi, Elena
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (03): : 338 - 347
  • [27] Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients
    Lee, Sung-Eun
    Jeon, Young-Woo
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong Wook
    Min, Woo-Sung
    Kim, Myungshin
    Min, Chang-Ki
    THROMBOSIS RESEARCH, 2015, 136 (05) : 974 - 979
  • [28] Effects of Multiple Myeloma (MM) Therapy and Type of Thromboprophylaxis On the Incidence and Timing of Venous Thromboembolism (VTE) and Factors Predictive of VTE
    Shah, Jatin J.
    Hegde, Aparna
    Zhou, Xiao
    Thomas, Sheeba K.
    Wang, Michael
    Weber, Donna M.
    Alexanian, Raymond
    Orlowski, Robert Z.
    Vadhan-Raj, Saroj
    BLOOD, 2012, 120 (21)
  • [29] Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients
    Chalayer, Emilie
    Tardy-Poncet, Brigitte
    Montmartin, Aurelie
    Boussoualim, Karima
    Genthon, Alexis
    Tardy, Bernard
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 186 (02) : 337 - 339
  • [30] Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review
    Al-Ani, Fatimah
    Louzada, Martha L.
    Bastida Bermejo, Jose Maria
    Victoria Mateos, Maria
    BLOOD, 2015, 126 (23)
12345